1. Home
  2. TDY vs MRNA Comparison

TDY vs MRNA Comparison

Compare TDY & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teledyne Technologies Incorporated

TDY

Teledyne Technologies Incorporated

HOLD

Current Price

$650.94

Market Cap

28.9B

Sector

Industrials

ML Signal

HOLD

Logo Moderna Inc.

MRNA

Moderna Inc.

HOLD

Current Price

$79.08

Market Cap

26.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDY
MRNA
Founded
1960
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
26.7B
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
TDY
MRNA
Price
$650.94
$79.08
Analyst Decision
Buy
Hold
Analyst Count
7
12
Target Price
$693.71
$34.27
AVG Volume (30 Days)
302.0K
8.0M
Earning Date
04-22-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
9.70
21.77
EPS
4.85
N/A
Revenue
$1,020,400,000.00
$19,263,000,000.00
Revenue This Year
$5.54
$9.36
Revenue Next Year
$5.08
$15.43
P/E Ratio
$134.54
N/A
Revenue Growth
N/A
4.29
52 Week Low
$483.02
$22.28
52 Week High
$693.38
$81.40

Technical Indicators

Market Signals
Indicator
TDY
MRNA
Relative Strength Index (RSI) 59.05 79.87
Support Level $627.29 $45.69
Resistance Level $679.74 N/A
Average True Range (ATR) 18.49 5.44
MACD 5.08 2.10
Stochastic Oscillator 67.27 95.25

Price Performance

Historical Comparison
TDY
MRNA

About TDY Teledyne Technologies Incorporated

Teledyne Technologies Inc provides enabling technologies to sense, analyze and distribute information for industrial growth markets that require advanced technology and high reliability. The firm operates in four segments: Digital Imaging, Instrumentation, Aerospace and Defense Electronics, and Engineered Systems. The Digital Imaging segment, that derives maximum revenue, includes high-performance sensors, cameras and systems, within the visible, infrared and X-ray spectra for use in industrial, government and medical applications, as well as MEMS and high-performance, high-reliability semiconductors including analog-to-digital and digital-to-analog converters. Geographically, the company operates in United States, Europe, Asia, and All other.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: